[Nasdaq-Listed Company Enlivex Therapeutics Plans to Raise $212 Million to Establish RAIN Token Treasury] BlockBeats News, November 24, according to The Block, Nasdaq-listed clinical-stage biopharmaceutical company Enlivex Therapeutics plans to raise $212 million through private financing to create a digital asset reserve built around the prediction market token Rain—this will be the world's first publicly listed company asset reserve program centered on a prediction market token. Rain, which describes itself as a 'fully decentralized prediction market protocol on the Arbitrum network,' allows users to create various event prediction markets in any language, with outcomes determined by AI and featuring a token buyback and burn mechanism.